Ruochen Li

1.6k total citations
42 papers, 1.0k citations indexed

About

Ruochen Li is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Ruochen Li has authored 42 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 20 papers in Immunology and 10 papers in Molecular Biology. Recurrent topics in Ruochen Li's work include Cancer Immunotherapy and Biomarkers (16 papers), Immune Cell Function and Interaction (13 papers) and Gastric Cancer Management and Outcomes (8 papers). Ruochen Li is often cited by papers focused on Cancer Immunotherapy and Biomarkers (16 papers), Immune Cell Function and Interaction (13 papers) and Gastric Cancer Management and Outcomes (8 papers). Ruochen Li collaborates with scholars based in China and Sweden. Ruochen Li's co-authors include Chao Lin, Hongyong He, Hao Liu, Heng Zhang, Jiejie Xu, Weijuan Zhang, Jieti Wang, He Li, Yun Gu and Kunpeng Lv and has published in prestigious journals such as Nature Communications, Annals of Surgery and Gut.

In The Last Decade

Ruochen Li

40 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruochen Li China 18 575 553 313 254 188 42 1.0k
Yifan Cao China 14 290 0.5× 249 0.5× 175 0.6× 136 0.5× 95 0.5× 29 529
Kouichirou Tahara Japan 15 506 0.9× 713 1.3× 457 1.5× 98 0.4× 124 0.7× 23 1.1k
Shenghua Zhan China 16 377 0.7× 312 0.6× 435 1.4× 110 0.4× 267 1.4× 34 954
Sarabjot Pabla United States 15 422 0.7× 251 0.5× 199 0.6× 153 0.6× 179 1.0× 77 720
Yuko Hosoe Japan 13 853 1.5× 704 1.3× 326 1.0× 198 0.8× 157 0.8× 21 1.3k
Anna-Maria Jegg Switzerland 4 397 0.7× 538 1.0× 205 0.7× 111 0.4× 76 0.4× 4 836
Zicheng Yu China 13 310 0.5× 147 0.3× 174 0.6× 117 0.5× 115 0.6× 28 611
Fuqiang Dai China 11 318 0.6× 364 0.7× 263 0.8× 213 0.8× 163 0.9× 21 793
Marina Vignoli Italy 12 182 0.3× 274 0.5× 165 0.5× 71 0.3× 65 0.3× 22 640

Countries citing papers authored by Ruochen Li

Since Specialization
Citations

This map shows the geographic impact of Ruochen Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruochen Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruochen Li more than expected).

Fields of papers citing papers by Ruochen Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruochen Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruochen Li. The network helps show where Ruochen Li may publish in the future.

Co-authorship network of co-authors of Ruochen Li

This figure shows the co-authorship network connecting the top 25 collaborators of Ruochen Li. A scholar is included among the top collaborators of Ruochen Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruochen Li. Ruochen Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Ruochen, Shan Li, Yuxin Peng, et al.. (2025). Noradrenergic inputs from the locus coeruleus to anterior piriform cortex and the olfactory bulb modulate olfactory outputs. Nature Communications. 16(1). 260–260.
2.
Sun, Mengyao, Yun Gu, Jieti Wang, et al.. (2025). Smad4 loss identifies aggressive subtype with immunotherapy and anti-HER-2 treatment resistance in gastric cancer. British Journal of Cancer. 132(12). 1148–1157.
3.
Sun, Di, Jiao Li, Chenghui Lu, et al.. (2025). Reflective analysis on the current 131I adjuvant therapy indications in intermediate- and high-risk differentiated thyroid cancer. European Journal of Nuclear Medicine and Molecular Imaging. 52(9). 3125–3134. 1 indexed citations
4.
Duan, Qiong, et al.. (2024). Ginkgetin enhances breast cancer radiotherapy sensitization by suppressing NRF2-HO-1 axis activity. Toxicology and Applied Pharmacology. 495. 117199–117199. 3 indexed citations
5.
Gu, Yun, Mengyao Sun, Hanji Fang, et al.. (2024). Impact of clonal TP53 mutations with loss of heterozygosity on adjuvant chemotherapy and immunotherapy in gastric cancer. British Journal of Cancer. 131(8). 1320–1327. 8 indexed citations
6.
Li, Ruochen, et al.. (2023). Ten‐year clinical characteristics of patients with early‐onset type 2 diabetes: A single‐center experience in China. Journal of Diabetes. 16(1). e13477–e13477. 3 indexed citations
7.
Lv, Kunpeng, Mengyao Sun, Hanji Fang, et al.. (2023). Targeting myeloid checkpoint Siglec-10 reactivates antitumor immunity and improves anti-programmed cell death 1 efficacy in gastric cancer. Journal for ImmunoTherapy of Cancer. 11(11). e007669–e007669. 15 indexed citations
8.
Gu, Yun, Jieti Wang, Kunpeng Lv, et al.. (2023). Complement receptor C5aR1 blockade reprograms tumor‐associated macrophages and synergizes with anti‐PD‐1 therapy in gastric cancer. International Journal of Cancer. 153(1). 224–237. 14 indexed citations
9.
Li, Ruochen, et al.. (2023). The value of percutaneous ultrasound-guided subacromial bursography in the diagnosis of rotator cuff tears. Medical Ultrasonography. 25(1). 48–48. 2 indexed citations
10.
Yu, Kuan, Yun Gu, Hanji Fang, et al.. (2022). Intratumoral PD-1+CD8+ T cells associate poor clinical outcomes and adjuvant chemotherapeutic benefit in gastric cancer. British Journal of Cancer. 127(9). 1709–1717. 23 indexed citations
11.
Wu, Tingting, Shan Li, Ruochen Li, et al.. (2022). Olfactory–auditory sensory integration in the lateral entorhinal cortex. Progress in Neurobiology. 221. 102399–102399. 9 indexed citations
12.
Gu, Yun, Jieti Wang, Chao Lin, et al.. (2022). Somatic ARID1A mutation stratifies patients with gastric cancer to PD-1 blockade and adjuvant chemotherapy. Cancer Immunology Immunotherapy. 72(5). 1199–1208. 23 indexed citations
13.
He, Xudong, Yifan Cao, Yun Gu, et al.. (2021). Clinical Outcomes and Immune Metrics in Intratumoral Basophil-Enriched Gastric Cancer Patients. Annals of Surgical Oncology. 28(11). 6439–6450. 20 indexed citations
14.
Fei, Yuchao, Yun Gu, Hanji Fang, et al.. (2021). Intratumoral Foxp3+RORγt+ T cell infiltration determines poor prognosis and immunoevasive contexture in gastric cancer patients. Cancer Immunology Immunotherapy. 71(1). 1–11. 8 indexed citations
15.
Wang, Jieti, Ruochen Li, Yifan Cao, et al.. (2021). Intratumoral CXCR5+CD8+T associates with favorable clinical outcomes and immunogenic contexture in gastric cancer. Nature Communications. 12(1). 3080–3080. 56 indexed citations
16.
Cheng, Yirui, Qingyu Zeng, Ruochen Li, et al.. (2020). Comparison of serum exosome isolation methods on co-precipitated free microRNAs. PeerJ. 8. e9434–e9434. 20 indexed citations
17.
Li, Ruochen, Hao Liu, Jieti Wang, et al.. (2020). Identification and validation of an immunogenic subtype of gastric cancer with abundant intratumoural CD103+CD8+ T cells conferring favourable prognosis. British Journal of Cancer. 122(10). 1525–1534. 36 indexed citations
18.
Lin, Chao, Hongyong He, Hao Liu, et al.. (2019). Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer. Gut. 68(10). 1764–1773. 283 indexed citations
19.
Wu, Song‐Yang, Hao Liu, Heng Zhang, et al.. (2016). Galectin-8 is associated with recurrence and survival of patients with non-metastatic gastric cancer after surgery. Tumor Biology. 37(9). 12635–12642. 17 indexed citations
20.
Cao, Yifan, Hao Liu, Heng Zhang, et al.. (2016). Decreased expression of Siglec-8 associates with poor prognosis in patients with gastric cancer after surgical resection. Tumor Biology. 37(8). 10883–10891. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026